This Article Full Text (OnlineFirst PDF) All Versions of this Article: 1756283X09337180v1 2/4/239    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Scopus Google Scholar Articles by Louis, E Articles by Reenaers, C Social Bookmarking                         What's this?

Tailoring the treatment to the individual in Crohn’s disease

University of Liège

^* To whom correspondence should be addressed. E-mail: edouard.louis{at}ulg.ac.be.

	Abstract

Crohn's disease is a heterogeneous disease with approximately 30–40% of patients having a simple benign history and the rest having a chronic progressive disease leading to complications, surgeries and potentially socio-professional marginalisation. Recent studies have shown that an early treatment with immunosuppressive treatment and/or anti-tumour necrosis factor agents could change the natural history of the disease and avoid the development of such disabling disease. The therapy should thus be tailored according to the risk of developing such disabling disease. Recent cohort studies have shown that clinical factors such as age at diagnosis, disease extent, disease location and behaviour at diagnosis were predictive for the development of severe or disabling disease and could be used in helping the physician to tailor therapy.

First published on June 4, 2009, doi:10.1177/1756283X09337180

Therapeutic Advances in Gastroenterology 2009;2:239.

A more recent version of this article appeared on July 1, 2009


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?